STOCK TITAN

Scryb Announces Private Placement Extension

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Scryb Inc. announces an extension of its non-brokered private placement financing, aiming to raise up to $1,500,000 through the issuance of 60,000,000 units at $0.025 per unit. The offering has been extended until May 31, 2024, with each unit consisting of a common share and a warrant. Proceeds will be utilized for working capital and general corporate purposes, subject to regulatory approvals.

Positive
  • Extended private placement financing provides Scryb Inc. with additional capital for operational needs and growth opportunities.

Negative
  • The hold period of four months plus a day for the securities issued may limit immediate liquidity for investors.

  • Regulatory approvals, including from the Canadian Securities Exchange, are required before the closing of the offering, introducing potential delays and uncertainties.

Toronto, Ontario--(Newsfile Corp. - May 9, 2024) - Scryb Inc. (CSE: SCYB) (OTCQB: SCYRF) (FSE: EIY) ("Scryb'' or the "Company"), is pleased to announce that, further to its press release of April 1, 2024, the Company's non-brokered private placement financing for gross proceeds of up to $1,500,000 through the issuance of up to 60,000,000 units in the capital of the Company (the "Units") at a price of $0.025 per Unit (the "Offering"), has been extended to May 31, 2024.

Each Unit shall be comprised of one common share in the capital of the Company (each, a "Common Share") and one whole Common Share purchase warrant (each, a "Warrant"). Each Warrant entitles the holder thereof to acquire one Common Share at a price of $0.05 per Common Share until the date that is eighteen (18) months from the date of issuance. Gross proceeds raised from the Offering will be used for working capital and general corporate purposes.

Closing of the Offering is subject to receipt of all necessary corporate and regulatory approvals, including the approval of Canadian Securities Exchange. All securities issued in connection with the Offering will be subject to a hold period of four months plus a day from the date of issuance and the resale rules of applicable securities legislation.

This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons as defined under applicable United States securities laws unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

About Scryb Inc.

Scryb, a leading venture builder, specializes in the development and scaling of high-growth, disruptive businesses within the sectors of applied AI, digital health, cybersecurity, and biotech. The approach at Scryb centers on leveraging deep industry expertise to shape and drive the future of technology. Among its notable ventures is a cybersecurity company where Scryb maintains majority ownership. For further information about Scryb's innovative projects and vision, please visit our website at http://scryb.ai.

Contact:
W. Clark Kent
President
Office. 647-872-9982
TF. 1-844-247-6633
Email: info@scryb.ai

Forward-looking Information Cautionary Statement

Except for statements of historic fact, this news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE. There are uncertainties inherent in forward-looking information, including factors beyond the Company's control. There are no assurances that the commercialization plans for the technology described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company's filings with Canadian securities regulators, which filings are available at www.sedar.com

NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/208584

FAQ

What is the purpose of Scryb Inc.'s private placement extension?

Scryb Inc.'s private placement extension aims to raise up to $1,500,000 for working capital and general corporate purposes.

How many units are being issued in the private placement financing?

Scryb Inc. plans to issue up to 60,000,000 units at a price of $0.025 per unit in the private placement financing.

Until when has the private placement financing been extended?

The private placement financing has been extended until May 31, 2024.

What does each unit in the private placement consist of?

Each unit in the private placement includes one common share and one whole common share purchase warrant.

What is the price at which the warrant holder can acquire a common share?

The warrant holder can acquire a common share at a price of $0.05 per share until eighteen months from the date of issuance.

Scryb Inc.

OTC:SCYRF

SCYRF Rankings

SCYRF Latest News

SCYRF Stock Data

6.98M
246.20M
3.92%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
Toronto